Cerner Corp. plans to acquire Kantar Well being, an information, analytics and analysis consultancy serving the life science trade, for $375 million in money.
A division of Kantar Group, Kantar Well being contains a whole bunch of associates with information analytics experience in addition to real-world information belongings. Cerner hopes to realize “significant entry to the pharmaceutical market by way of Kantar Well being’s shopper relationships and their robust management staff with essential trade expertise and relationships,” Christy Dueck, vp of Information as a Service, Cerner, stated in an e mail.
By means of the acquisition, Cerner will supply its Studying Well being Community purchasers direct engagement with the life sciences trade for funded analysis research, she stated. The Cerner Studying Well being Community presents member well being programs free entry to a community of standardized, de-identified information and sources to assist analysis efforts.
As well as, the acquisition will present Cerner purchasers entry to Kantar’s staff of clinicians and researchers who may help them derive insights from information belongings like EHRs, claims in addition to from its personal proprietary information belongings which are targeted on uncommon ailments, oncology and patient-reported outcomes, Dueck stated.
“Cerner believes there’s a distinctive alternative centered between suppliers, real-world scientific information and life sciences the place scientific trials and good medical analysis could be extra accessible to sufferers whereas considerably reducing the price of drug discovery,” she added.
The acquisition is anticipated to shut within the first half of 2021, and it’s topic to regulatory approval, worker consultations and different circumstances. It isn’t anticipated to have a fabric impression on Cerner’s earnings subsequent 12 months.
“There’s a robust cultural match between the 2 organizations, grounded by our shared imaginative and prescient to extend entry and affordability for sufferers around the globe,” stated Lynnette Cooke, CEO of Kantar Well being, in response to a press launch. “We anticipate the mix of our experience and belongings with Cerner’s expertise and distinctive insights into sufferers will allow a step-change in the way in which healthcare is developed and delivered, leading to improved affected person outcomes.”
The acquisition of Kantar Well being comes a few week after Cerner announced an investment in Elligo Well being Analysis, an built-in analysis group that permits scientific trials with community-based healthcare practices. Cerner plans to enter right into a industrial settlement with Elligo to supply further scientific trial sources to suppliers within the Cerner Studying Well being Community.
Picture credit score: Natee Meepian, Getty Photographs